Cervical Cancer – Pipeline Review, H1 2017, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/323663 .
Cervical cancer occurs when abnormal cells on the cervix grow out of control. Most cervical cancer is caused by a virus called human papillomavirus, or HPV. Abnormal cervical cell changes rarely cause symptoms. Symptoms of cervical cancer may include abnormal vaginal bleeding, such as bleeding after sex (vaginal intercourse), bleeding after menopause, bleeding and spotting between periods, and having longer or heavier (menstrual) periods than usual. Treatment options include surgery, radiation therapy, chemotherapy or a combination of methods.
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Cervical Cancer – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cervical Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Browse the full report @ http://www.orbisresearch.com/reports/index/cervical-cancer-pipeline-review-h1-2017 .
The Cervical Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 32, 32, 47, 4 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 5, 2, 11 and 4 molecules, respectively.
Cervical Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
– The pipeline guide provides a snapshot of the global therapeutic landscape of Cervical Cancer (Oncology).
– The pipeline guide reviews pipeline therapeutics for Cervical Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Cervical Cancer (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Cervical Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Cervical Cancer (Oncology)
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/323663 .
Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Cervical Cancer (Oncology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Cervical Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Advenchen Laboratories LLC
Antigen Express Inc
Arbor Vita Corp
Asana BioSciences LLC
Atara Biotherapeutics Inc
AVEO Pharmaceuticals Inc
Biomics Biotechnologies Co Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Cancer Research Technology Ltd
Cell Medica Ltd
Celleron Therapeutics Ltd
Coherus BioSciences Inc
Critical Outcome Technologies Inc
Cytori Therapeutics Inc
CZ BioMed Corp
DelMar Pharmaceuticals Inc
Dr. Reddy’s Laboratories Ltd
Eisai Co Ltd
Eureka Therapeutics Inc
F. Hoffmann-La Roche Ltd
GamaMabs Pharma SA
Gene Techno Science Co Ltd
Genor BioPharma Co Ltd
Glycostem Therapeutics BV
Immune Therapeutics Inc
Insys Therapeutics Inc
ISA Pharmaceuticals BV
Johnson & Johnson
Juno Therapeutics Inc
Karyopharm Therapeutics Inc
Kite Pharma Inc
Lion Biotechnologies Inc
Merck & Co Inc
Mycenax Biotech Inc
Oryx GmbH & Co KG
PDS Biotechnology Corp
Pharma Mar SA
Psicofarma SA de CV
Puma Biotechnology Inc
Rexahn Pharmaceuticals Inc
Richter Gedeon Nyrt
Samyang Holdings Corp
Seattle Genetics Inc
Selecta Biosciences Inc
Shantha Biotechnics Pvt Ltd
Sun Pharma Advanced Research Company Ltd
Taiho Pharmaceutical Co Ltd
Tessa Therapeutics Pte Ltd
THEVAX Genetics Vaccine USA Inc
Wellstat Biologics Corp
Zeria Pharmaceutical Co Ltd
Zydus Cadila Healthcare Ltd
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For more information contact email@example.com